Global Human Coagulation Factor Ⅷ Market Growth 2022-2028

LP 4853036
109 Pages
February 2022
Pharmaceuticals

Download Sample Get Discount

As the global economy mends, the 2021 growth of Human Coagulation Factor �

� will have significant change from previous year. According to our (LP Information) latest study, the global Human Coagulation Factor �

� market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Human Coagulation Factor �

� market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Human Coagulation Factor �

� market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Human Coagulation Factor �

� market, reaching US$ million by the year 2028. As for the Europe Human Coagulation Factor �

� landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Human Coagulation Factor �

� players cover Bayer, CSL Behring, Baxter, and Grifols, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Human Coagulation Factor �

� market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Recombinant Factor VIII

Human Factor VIII

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Hemophilia A

Relvent Bleeding Diseases

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Bayer

CSL Behring

Baxter

Grifols

Octapharma

Pfizer

Taibang Bio

Shanghai Laishi

Hualan Bio

Guangdong Shuanglin

GreenCross

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Human Coagulation Factor �

� Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Human Coagulation Factor �

� by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Human Coagulation Factor �

� by Country/Region, 2017, 2022 & 2028

2.2 Human Coagulation Factor �

� Segment by Type

2.2.1 Recombinant Factor VIII

2.2.2 Human Factor VIII

2.3 Human Coagulation Factor �

� Sales by Type

2.3.1 Global Human Coagulation Factor �

� Sales Market Share by Type (2017-2022)

2.3.2 Global Human Coagulation Factor �

� Revenue and Market Share by Type (2017-2022)

2.3.3 Global Human Coagulation Factor �

� Sale Price by Type (2017-2022)

2.4 Human Coagulation Factor �

� Segment by Application

2.4.1 Hemophilia A

2.4.2 Relvent Bleeding Diseases

2.5 Human Coagulation Factor �

� Sales by Application

2.5.1 Global Human Coagulation Factor �

� Sale Market Share by Application (2017-2022)

2.5.2 Global Human Coagulation Factor �

� Revenue and Market Share by Application (2017-2022)

2.5.3 Global Human Coagulation Factor �

� Sale Price by Application (2017-2022)

3 Global Human Coagulation Factor �

� by Company

3.1 Global Human Coagulation Factor �

� Breakdown Data by Company

3.1.1 Global Human Coagulation Factor �

� Annual Sales by Company (2020-2022)

3.1.2 Global Human Coagulation Factor �

� Sales Market Share by Company (2020-2022)

3.2 Global Human Coagulation Factor �

� Annual Revenue by Company (2020-2022)

3.2.1 Global Human Coagulation Factor �

� Revenue by Company (2020-2022)

3.2.2 Global Human Coagulation Factor �

� Revenue Market Share by Company (2020-2022)

3.3 Global Human Coagulation Factor �

� Sale Price by Company

3.4 Key Manufacturers Human Coagulation Factor �

� Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Human Coagulation Factor �

� Product Location Distribution

3.4.2 Players Human Coagulation Factor �

� Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Human Coagulation Factor �

� by Geographic Region

4.1 World Historic Human Coagulation Factor �

� Market Size by Geographic Region (2017-2022)

4.1.1 Global Human Coagulation Factor �

� Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Human Coagulation Factor �

� Annual Revenue by Geographic Region

4.2 World Historic Human Coagulation Factor �

� Market Size by Country/Region (2017-2022)

4.2.1 Global Human Coagulation Factor �

� Annual Sales by Country/Region (2017-2022)

4.2.2 Global Human Coagulation Factor �

� Annual Revenue by Country/Region

4.3 Americas Human Coagulation Factor �

� Sales Growth

4.4 APAC Human Coagulation Factor �

� Sales Growth

4.5 Europe Human Coagulation Factor �

� Sales Growth

4.6 Middle East & Africa Human Coagulation Factor �

� Sales Growth

5 Americas

5.1 Americas Human Coagulation Factor �

� Sales by Country

5.1.1 Americas Human Coagulation Factor �

� Sales by Country (2017-2022)

5.1.2 Americas Human Coagulation Factor �

� Revenue by Country (2017-2022)

5.2 Americas Human Coagulation Factor �

� Sales by Type

5.3 Americas Human Coagulation Factor �

� Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Human Coagulation Factor �

� Sales by Region

6.1.1 APAC Human Coagulation Factor �

� Sales by Region (2017-2022)

6.1.2 APAC Human Coagulation Factor �

� Revenue by Region (2017-2022)

6.2 APAC Human Coagulation Factor �

� Sales by Type

6.3 APAC Human Coagulation Factor �

� Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Human Coagulation Factor �

� by Country

7.1.1 Europe Human Coagulation Factor �

� Sales by Country (2017-2022)

7.1.2 Europe Human Coagulation Factor �

� Revenue by Country (2017-2022)

7.2 Europe Human Coagulation Factor �

� Sales by Type

7.3 Europe Human Coagulation Factor �

� Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Human Coagulation Factor �

� by Country

8.1.1 Middle East & Africa Human Coagulation Factor �

� Sales by Country (2017-2022)

8.1.2 Middle East & Africa Human Coagulation Factor �

� Revenue by Country (2017-2022)

8.2 Middle East & Africa Human Coagulation Factor �

� Sales by Type

8.3 Middle East & Africa Human Coagulation Factor �

� Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Human Coagulation Factor �

�

10.3 Manufacturing Process Analysis of Human Coagulation Factor �

�

10.4 Industry Chain Structure of Human Coagulation Factor �

�

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Human Coagulation Factor �

� Distributors

11.3 Human Coagulation Factor �

� Customer

12 World Forecast Review for Human Coagulation Factor �

� by Geographic Region

12.1 Global Human Coagulation Factor �

� Market Size Forecast by Region

12.1.1 Global Human Coagulation Factor �

� Forecast by Region (2023-2028)

12.1.2 Global Human Coagulation Factor �

� Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Human Coagulation Factor �

� Forecast by Type

12.7 Global Human Coagulation Factor �

� Forecast by Application

13 Key Players Analysis

13.1 Bayer

13.1.1 Bayer Company Information

13.1.2 Bayer Human Coagulation Factor �

� Product Offered

13.1.3 Bayer Human Coagulation Factor �

� Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Bayer Main Business Overview

13.1.5 Bayer Latest Developments

13.2 CSL Behring

13.2.1 CSL Behring Company Information

13.2.2 CSL Behring Human Coagulation Factor �

� Product Offered

13.2.3 CSL Behring Human Coagulation Factor �

� Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 CSL Behring Main Business Overview

13.2.5 CSL Behring Latest Developments

13.3 Baxter

13.3.1 Baxter Company Information

13.3.2 Baxter Human Coagulation Factor �

� Product Offered

13.3.3 Baxter Human Coagulation Factor �

� Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Baxter Main Business Overview

13.3.5 Baxter Latest Developments

13.4 Grifols

13.4.1 Grifols Company Information

13.4.2 Grifols Human Coagulation Factor �

� Product Offered

13.4.3 Grifols Human Coagulation Factor �

� Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Grifols Main Business Overview

13.4.5 Grifols Latest Developments

13.5 Octapharma

13.5.1 Octapharma Company Information

13.5.2 Octapharma Human Coagulation Factor �

� Product Offered

13.5.3 Octapharma Human Coagulation Factor �

� Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Octapharma Main Business Overview

13.5.5 Octapharma Latest Developments

13.6 Pfizer

13.6.1 Pfizer Company Information

13.6.2 Pfizer Human Coagulation Factor �

� Product Offered

13.6.3 Pfizer Human Coagulation Factor �

� Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Pfizer Main Business Overview

13.6.5 Pfizer Latest Developments

13.7 Taibang Bio

13.7.1 Taibang Bio Company Information

13.7.2 Taibang Bio Human Coagulation Factor �

� Product Offered

13.7.3 Taibang Bio Human Coagulation Factor �

� Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Taibang Bio Main Business Overview

13.7.5 Taibang Bio Latest Developments

13.8 Shanghai Laishi

13.8.1 Shanghai Laishi Company Information

13.8.2 Shanghai Laishi Human Coagulation Factor �

� Product Offered

13.8.3 Shanghai Laishi Human Coagulation Factor �

� Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Shanghai Laishi Main Business Overview

13.8.5 Shanghai Laishi Latest Developments

13.9 Hualan Bio

13.9.1 Hualan Bio Company Information

13.9.2 Hualan Bio Human Coagulation Factor �

� Product Offered

13.9.3 Hualan Bio Human Coagulation Factor �

� Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Hualan Bio Main Business Overview

13.9.5 Hualan Bio Latest Developments

13.10 Guangdong Shuanglin

13.10.1 Guangdong Shuanglin Company Information

13.10.2 Guangdong Shuanglin Human Coagulation Factor �

� Product Offered

13.10.3 Guangdong Shuanglin Human Coagulation Factor �

� Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Guangdong Shuanglin Main Business Overview

13.10.5 Guangdong Shuanglin Latest Developments

13.11 GreenCross

13.11.1 GreenCross Company Information

13.11.2 GreenCross Human Coagulation Factor �

� Product Offered

13.11.3 GreenCross Human Coagulation Factor �

� Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 GreenCross Main Business Overview

13.11.5 GreenCross Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Human Coagulation Factor �

� Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Human Coagulation Factor �

� Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Recombinant Factor VIII

Table 4. Major Players of Human Factor VIII

Table 5. Global Human Coagulation Factor �

� Sales by Type (2017-2022) & (K Units)

Table 6. Global Human Coagulation Factor �

� Sales Market Share by Type (2017-2022)

Table 7. Global Human Coagulation Factor �

� Revenue by Type (2017-2022) & ($ million)

Table 8. Global Human Coagulation Factor �

� Revenue Market Share by Type (2017-2022)

Table 9. Global Human Coagulation Factor �

� Sale Price by Type (2017-2022) & (US$/Unit)

Table 10. Global Human Coagulation Factor �

� Sales by Application (2017-2022) & (K Units)

Table 11. Global Human Coagulation Factor �

� Sales Market Share by Application (2017-2022)

Table 12. Global Human Coagulation Factor �

� Revenue by Application (2017-2022)

Table 13. Global Human Coagulation Factor �

� Revenue Market Share by Application (2017-2022)

Table 14. Global Human Coagulation Factor �

� Sale Price by Application (2017-2022) & (US$/Unit)

Table 15. Global Human Coagulation Factor �

� Sales by Company (2020-2022) & (K Units)

Table 16. Global Human Coagulation Factor �

� Sales Market Share by Company (2020-2022)

Table 17. Global Human Coagulation Factor �

� Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Human Coagulation Factor �

� Revenue Market Share by Company (2020-2022)

Table 19. Global Human Coagulation Factor �

� Sale Price by Company (2020-2022) & (US$/Unit)

Table 20. Key Manufacturers Human Coagulation Factor �

� Producing Area Distribution and Sales Area

Table 21. Players Human Coagulation Factor �

� Products Offered

Table 22. Human Coagulation Factor �

� Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Human Coagulation Factor �

� Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Human Coagulation Factor �

� Sales Market Share Geographic Region (2017-2022)

Table 27. Global Human Coagulation Factor �

� Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Human Coagulation Factor �

� Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Human Coagulation Factor �

� Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Human Coagulation Factor �

� Sales Market Share by Country/Region (2017-2022)

Table 31. Global Human Coagulation Factor �

� Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Human Coagulation Factor �

� Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Human Coagulation Factor �

� Sales by Country (2017-2022) & (K Units)

Table 34. Americas Human Coagulation Factor �

� Sales Market Share by Country (2017-2022)

Table 35. Americas Human Coagulation Factor �

� Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Human Coagulation Factor �

� Revenue Market Share by Country (2017-2022)

Table 37. Americas Human Coagulation Factor �

� Sales by Type (2017-2022) & (K Units)

Table 38. Americas Human Coagulation Factor �

� Sales Market Share by Type (2017-2022)

Table 39. Americas Human Coagulation Factor �

� Sales by Application (2017-2022) & (K Units)

Table 40. Americas Human Coagulation Factor �

� Sales Market Share by Application (2017-2022)

Table 41. APAC Human Coagulation Factor �

� Sales by Region (2017-2022) & (K Units)

Table 42. APAC Human Coagulation Factor �

� Sales Market Share by Region (2017-2022)

Table 43. APAC Human Coagulation Factor �

� Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Human Coagulation Factor �

� Revenue Market Share by Region (2017-2022)

Table 45. APAC Human Coagulation Factor �

� Sales by Type (2017-2022) & (K Units)

Table 46. APAC Human Coagulation Factor �

� Sales Market Share by Type (2017-2022)

Table 47. APAC Human Coagulation Factor �

� Sales by Application (2017-2022) & (K Units)

Table 48. APAC Human Coagulation Factor �

� Sales Market Share by Application (2017-2022)

Table 49. Europe Human Coagulation Factor �

� Sales by Country (2017-2022) & (K Units)

Table 50. Europe Human Coagulation Factor �

� Sales Market Share by Country (2017-2022)

Table 51. Europe Human Coagulation Factor �

� Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Human Coagulation Factor �

� Revenue Market Share by Country (2017-2022)

Table 53. Europe Human Coagulation Factor �

� Sales by Type (2017-2022) & (K Units)

Table 54. Europe Human Coagulation Factor �

� Sales Market Share by Type (2017-2022)

Table 55. Europe Human Coagulation Factor �

� Sales by Application (2017-2022) & (K Units)

Table 56. Europe Human Coagulation Factor �

� Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Human Coagulation Factor �

� Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Human Coagulation Factor �

� Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Human Coagulation Factor �

� Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Human Coagulation Factor �

� Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Human Coagulation Factor �

� Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Human Coagulation Factor �

� Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Human Coagulation Factor �

� Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Human Coagulation Factor �

� Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Human Coagulation Factor �

�

Table 66. Key Market Challenges & Risks of Human Coagulation Factor �

�

Table 67. Key Industry Trends of Human Coagulation Factor �

�

Table 68. Human Coagulation Factor �

� Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Human Coagulation Factor �

� Distributors List

Table 71. Human Coagulation Factor �

� Customer List

Table 72. Global Human Coagulation Factor �

� Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Human Coagulation Factor �

� Sales Market Forecast by Region

Table 74. Global Human Coagulation Factor �

� Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Human Coagulation Factor �

� Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Human Coagulation Factor �

� Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Human Coagulation Factor �

� Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Human Coagulation Factor �

� Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Human Coagulation Factor �

� Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Human Coagulation Factor �

� Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Human Coagulation Factor �

� Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Human Coagulation Factor �

� Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Human Coagulation Factor �

� Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Human Coagulation Factor �

� Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Human Coagulation Factor �

� Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Human Coagulation Factor �

� Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Human Coagulation Factor �

� Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Human Coagulation Factor �

� Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Human Coagulation Factor �

� Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Human Coagulation Factor �

� Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Human Coagulation Factor �

� Revenue Market Share Forecast by Application (2023-2028)

Table 92. Bayer Basic Information, Human Coagulation Factor �

� Manufacturing Base, Sales Area and Its Competitors

Table 93. Bayer Human Coagulation Factor �

� Product Offered

Table 94. Bayer Human Coagulation Factor �

� Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 95. Bayer Main Business

Table 96. Bayer Latest Developments

Table 97. CSL Behring Basic Information, Human Coagulation Factor �

� Manufacturing Base, Sales Area and Its Competitors

Table 98. CSL Behring Human Coagulation Factor �

� Product Offered

Table 99. CSL Behring Human Coagulation Factor �

� Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 100. CSL Behring Main Business

Table 101. CSL Behring Latest Developments

Table 102. Baxter Basic Information, Human Coagulation Factor �

� Manufacturing Base, Sales Area and Its Competitors

Table 103. Baxter Human Coagulation Factor �

� Product Offered

Table 104. Baxter Human Coagulation Factor �

� Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 105. Baxter Main Business

Table 106. Baxter Latest Developments

Table 107. Grifols Basic Information, Human Coagulation Factor �

� Manufacturing Base, Sales Area and Its Competitors

Table 108. Grifols Human Coagulation Factor �

� Product Offered

Table 109. Grifols Human Coagulation Factor �

� Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 110. Grifols Main Business

Table 111. Grifols Latest Developments

Table 112. Octapharma Basic Information, Human Coagulation Factor �

� Manufacturing Base, Sales Area and Its Competitors

Table 113. Octapharma Human Coagulation Factor �

� Product Offered

Table 114. Octapharma Human Coagulation Factor �

� Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 115. Octapharma Main Business

Table 116. Octapharma Latest Developments

Table 117. Pfizer Basic Information, Human Coagulation Factor �

� Manufacturing Base, Sales Area and Its Competitors

Table 118. Pfizer Human Coagulation Factor �

� Product Offered

Table 119. Pfizer Human Coagulation Factor �

� Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 120. Pfizer Main Business

Table 121. Pfizer Latest Developments

Table 122. Taibang Bio Basic Information, Human Coagulation Factor �

� Manufacturing Base, Sales Area and Its Competitors

Table 123. Taibang Bio Human Coagulation Factor �

� Product Offered

Table 124. Taibang Bio Human Coagulation Factor �

� Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 125. Taibang Bio Main Business

Table 126. Taibang Bio Latest Developments

Table 127. Shanghai Laishi Basic Information, Human Coagulation Factor �

� Manufacturing Base, Sales Area and Its Competitors

Table 128. Shanghai Laishi Human Coagulation Factor �

� Product Offered

Table 129. Shanghai Laishi Human Coagulation Factor �

� Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 130. Shanghai Laishi Main Business

Table 131. Shanghai Laishi Latest Developments

Table 132. Hualan Bio Basic Information, Human Coagulation Factor �

� Manufacturing Base, Sales Area and Its Competitors

Table 133. Hualan Bio Human Coagulation Factor �

� Product Offered

Table 134. Hualan Bio Human Coagulation Factor �

� Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 135. Hualan Bio Main Business

Table 136. Hualan Bio Latest Developments

Table 137. Guangdong Shuanglin Basic Information, Human Coagulation Factor �

� Manufacturing Base, Sales Area and Its Competitors

Table 138. Guangdong Shuanglin Human Coagulation Factor �

� Product Offered

Table 139. Guangdong Shuanglin Human Coagulation Factor �

� Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 140. Guangdong Shuanglin Main Business

Table 141. Guangdong Shuanglin Latest Developments

Table 142. GreenCross Basic Information, Human Coagulation Factor �

� Manufacturing Base, Sales Area and Its Competitors

Table 143. GreenCross Human Coagulation Factor �

� Product Offered

Table 144. GreenCross Human Coagulation Factor �

� Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 145. GreenCross Main Business

Table 146. GreenCross Latest Developments

List of Figures

Figure 1. Picture of Human Coagulation Factor �

�

Figure 2. Human Coagulation Factor �

� Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Human Coagulation Factor �

� Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Human Coagulation Factor �

� Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Human Coagulation Factor �

� Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Recombinant Factor VIII

Figure 10. Product Picture of Human Factor VIII

Figure 11. Global Human Coagulation Factor �

� Sales Market Share by Type in 2021

Figure 12. Global Human Coagulation Factor �

� Revenue Market Share by Type (2017-2022)

Figure 13. Human Coagulation Factor �

� Consumed in Hemophilia A

Figure 14. Global Human Coagulation Factor �

� Market: Hemophilia A (2017-2022) & (K Units)

Figure 15. Human Coagulation Factor �

� Consumed in Relvent Bleeding Diseases

Figure 16. Global Human Coagulation Factor �

� Market: Relvent Bleeding Diseases (2017-2022) & (K Units)

Figure 17. Global Human Coagulation Factor �

� Sales Market Share by Application (2017-2022)

Figure 18. Global Human Coagulation Factor �

� Revenue Market Share by Application in 2021

Figure 19. Human Coagulation Factor �

� Revenue Market by Company in 2021 ($ Million)

Figure 20. Global Human Coagulation Factor �

� Revenue Market Share by Company in 2021

Figure 21. Global Human Coagulation Factor �

� Sales Market Share by Geographic Region (2017-2022)

Figure 22. Global Human Coagulation Factor �

� Revenue Market Share by Geographic Region in 2021

Figure 23. Global Human Coagulation Factor �

� Sales Market Share by Region (2017-2022)

Figure 24. Global Human Coagulation Factor �

� Revenue Market Share by Country/Region in 2021

Figure 25. Americas Human Coagulation Factor �

� Sales 2017-2022 (K Units)

Figure 26. Americas Human Coagulation Factor �

� Revenue 2017-2022 ($ Millions)

Figure 27. APAC Human Coagulation Factor �

� Sales 2017-2022 (K Units)

Figure 28. APAC Human Coagulation Factor �

� Revenue 2017-2022 ($ Millions)

Figure 29. Europe Human Coagulation Factor �

� Sales 2017-2022 (K Units)

Figure 30. Europe Human Coagulation Factor �

� Revenue 2017-2022 ($ Millions)

Figure 31. Middle East & Africa Human Coagulation Factor �

� Sales 2017-2022 (K Units)

Figure 32. Middle East & Africa Human Coagulation Factor �

� Revenue 2017-2022 ($ Millions)

Figure 33. Americas Human Coagulation Factor �

� Sales Market Share by Country in 2021

Figure 34. Americas Human Coagulation Factor �

� Revenue Market Share by Country in 2021

Figure 35. United States Human Coagulation Factor �